Zepbound, which is already sold by Eli Lilly as the diabetes treatment Mounjaro, was shown to reduce patients’ weight by as much as one-fifth in drug trials.
Tag: Novo Nordisk A/S
-
How Much Do Ozempic and Wegovy Cost? Not What You Think.
Drug companies are making billions from a new class of in-demand weight-loss treatments. But the prices are not what they seem.
-
Lawsuit Challenges Insurance Restrictions on Weight Loss Drugs Like Wegovy
Many employers and government programs won’t cover costly obesity medications. A lawsuit is challenging one such policy.
-
Ozempic Can’t Fix What Our Culture Has Broken
When women say that it is better to be sick and thin than healthy and fat, they are perfectly rational.
-
Ozempic and Wegovy, Novo Nordisk’s Weight Loss Drugs, Reshape Denmark’s Economy
Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of Denmark’s economic growth.